First National Advisers LLC Buys 4,987 Shares of Revvity Inc. (NYSE:RVTY)

Key Points

• First National Advisers LLC increased its stake in Revvity Inc. by 48.7% in the first quarter, owning a total of 15,225 shares valued at approximately $1.61 million.
• Revvity reported $1.01 earnings per share (EPS) for the last quarter, exceeding analysts' expectations of $0.96, with revenue rising 2.3% year-over-year.
• The company announced a quarterly dividend of $0.07 per share, reflecting a 0.27% annual yield, set to be paid on November 7th.

First National Advisers LLC lifted its stake in shares of Revvity Inc. (NYSE:RVTY - Free Report) by 48.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,225 shares of the company's stock after acquiring an additional 4,987 shares during the period. First National Advisers LLC's holdings in Revvity were worth $1,611,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the business. Optiver Holding B.V. acquired a new position in shares of Revvity during the 4th quarter worth about $33,000. Quarry LP raised its holdings in shares of Revvity by 45.7% in the 4th quarter. Quarry LP now owns 303 shares of the company's stock valued at $34,000 after purchasing an additional 95 shares during the period. Vermillion Wealth Management Inc. bought a new stake in shares of Revvity in the 4th quarter valued at about $41,000. Continuum Advisory LLC raised its holdings in shares of Revvity by 39.3% in the 4th quarter. Continuum Advisory LLC now owns 471 shares of the company's stock valued at $53,000 after purchasing an additional 133 shares during the period. Finally, GeoWealth Management LLC bought a new stake in shares of Revvity in the 4th quarter valued at about $60,000. Institutional investors and hedge funds own 86.65% of the company's stock.

Analyst Upgrades and Downgrades

RVTY has been the topic of a number of research analyst reports. Robert W. Baird dropped their target price on shares of Revvity from $127.00 to $125.00 and set an "outperform" rating on the stock in a report on Tuesday, April 29th. JPMorgan Chase & Co. dropped their target price on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating on the stock in a report on Tuesday, April 29th. Raymond James Financial reissued an "outperform" rating and issued a $115.00 price objective (down from $120.00) on shares of Revvity in a research report on Tuesday. Stifel Nicolaus dropped their price objective on shares of Revvity from $120.00 to $110.00 and set a "hold" rating on the stock in a research report on Tuesday. Finally, Evercore ISI dropped their price objective on shares of Revvity from $116.00 to $115.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 8th. Four equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $120.07.

Revvity Price Performance

RVTY stock traded down $1.68 during mid-day trading on Thursday, hitting $89.17. The stock had a trading volume of 696,630 shares, compared to its average volume of 1,182,417. The company has a current ratio of 3.33, a quick ratio of 2.99 and a debt-to-equity ratio of 0.43. Revvity Inc. has a 52 week low of $87.70 and a 52 week high of $129.50. The firm has a market capitalization of $10.51 billion, a P/E ratio of 37.81, a P/E/G ratio of 2.34 and a beta of 0.98. The firm has a fifty day simple moving average of $95.59 and a 200 day simple moving average of $102.99.

Revvity (NYSE:RVTY - Get Free Report) last released its earnings results on Monday, July 28th. The company reported $1.18 EPS for the quarter, beating the consensus estimate of $1.14 by $0.04. The firm had revenue of $720.28 million for the quarter, compared to analyst estimates of $711.26 million. Revvity had a net margin of 10.19% and a return on equity of 7.66%. The business's quarterly revenue was up 4.1% compared to the same quarter last year. During the same period last year, the firm earned $1.22 EPS. As a group, research analysts forecast that Revvity Inc. will post 4.94 EPS for the current year.

Revvity Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 7th. Investors of record on Friday, October 17th will be issued a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 0.31%. The ex-dividend date is Friday, October 17th. Revvity's dividend payout ratio (DPR) is presently 11.86%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.